Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.21.2
Revenue from Contracts with Customers (Tables)
9 Months Ended
Jun. 30, 2021
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

Nine Months Ended

June 30,

June 30,

2021

2020

2021

2020

FC2

U.S. prescription channel

$

13,501,862

$

5,391,523

$

32,916,343

$

18,395,280

Global public health sector

4,153,730

4,254,197

11,833,894

11,197,635

Total FC2

17,655,592

9,645,720

44,750,237

29,592,915

PREBOOST®

-

676,034

862,831

1,249,959

Net revenues

$

17,655,592

$

10,321,754

$

45,613,068

$

30,842,874

Revenue by Geographic Area

Three Months Ended

Nine Months Ended

June 30,

June 30,

2021

2020

2021

2020

United States

$

14,080,810

$

6,396,762

$

35,049,646

$

20,575,515

South Africa

*

1,182,225

*

*

Other

3,574,782

2,742,767

10,563,422

10,267,359

Net revenues

$

17,655,592

$

10,321,754

$

45,613,068

$

30,842,874

*Less than 10% of total net revenues